These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29855362)

  • 21. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis.
    Papakonstantinou E; Athanasiadou KI; Markozannes G; Tzotzola V; Bouka E; Baka M; Moschovi M; Polychronopoulou S; Hatzipantelis E; Galani V; Stefanaki K; Strantzia K; Vousvouki M; Kourou P; Magkou E; Nikita M; Zambakides C; Michelarakis J; Alexopoulou A; Gavra M; Malama A; Ntzani EE; Petridou ET
    Cancer Epidemiol; 2024 Jun; 90():102551. PubMed ID: 38447251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
    Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
    Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
    Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
    BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
    Smeland S; Bielack SS; Whelan J; Bernstein M; Hogendoorn P; Krailo MD; Gorlick R; Janeway KA; Ingleby FC; Anninga J; Antal I; Arndt C; Brown KLB; Butterfass-Bahloul T; Calaminus G; Capra M; Dhooge C; Eriksson M; Flanagan AM; Friedel G; Gebhardt MC; Gelderblom H; Goldsby R; Grier HE; Grimer R; Hawkins DS; Hecker-Nolting S; Sundby Hall K; Isakoff MS; Jovic G; Kühne T; Kager L; von Kalle T; Kabickova E; Lang S; Lau CC; Leavey PJ; Lessnick SL; Mascarenhas L; Mayer-Steinacker R; Meyers PA; Nagarajan R; Randall RL; Reichardt P; Renard M; Rechnitzer C; Schwartz CL; Strauss S; Teot L; Timmermann B; Sydes MR; Marina N
    Eur J Cancer; 2019 Mar; 109():36-50. PubMed ID: 30685685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Osteosarcoma lung metastases. Survival after chemotherapy and surgery].
    Farfalli GL; Albergo JI; Lobos PA; Smith DE; Streitenberger PD; Pallotta Rodríguez MG; Aponte-Tinao LA
    Medicina (B Aires); 2015; 75(2):87-90. PubMed ID: 25919869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.
    Tsuchie H; Emori M; Nagasawa H; Miyakoshi N; Murahashi Y; Shimizu J; Mizushima E; Yamashita T; Shimada Y
    Med Princ Pract; 2019; 28(5):425-431. PubMed ID: 30991396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
    Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
    J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse impact of regional lymph node involvement in osteosarcoma.
    Thampi S; Matthay KK; Goldsby R; DuBois SG
    Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
    Harting MT; Lally KP; Andrassy RJ; Vaporciyan AA; Cox CS; Hayes-Jordan A; Blakely ML
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):561-70. PubMed ID: 19784847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.
    Pruksakorn D; Phanphaisarn A; Arpornchayanon O; Uttamo N; Leerapun T; Settakorn J
    Cancer Epidemiol; 2015 Dec; 39(6):956-63. PubMed ID: 26540607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma.
    Yong B; Tan P; Yin J; Zou C; Xie X; Wang J; Huang G; Wang Q; Shen J
    World J Surg Oncol; 2012 Sep; 10():191. PubMed ID: 22985081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
    Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S
    J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
    Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.
    Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X
    Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
    Palmerini E; Torricelli E; Cascinu S; Pierini M; De Paolis M; Donati D; Cesari M; Longhi A; Abate M; Paioli A; Setola E; Ferrari S
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27792. PubMed ID: 31058424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.